---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-002862"
form_type: "8-K"
ticker: "BAX"
cik: "0000010456"
company_name: "BAXTER INTERNATIONAL INC"
filed_at: "2023-02-09T23:59:59+00:00"
generated_at: "2026-06-19T19:06:40.893908+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Baxter reports Q4 sales $3.9B, full-year GAAP loss of $4.83 per share; spinoff update

## Summary
- Q4 revenue $3.9B (+11% reported, +17% constant currency); GAAP EPS $0.36, adjusted EPS $0.88.
- Full-year sales $15.1B (+18% reported); GAAP diluted EPS loss ($4.83); adjusted EPS $3.50.
- Company reiterates plans to spin off Renal Care and Acute Therapies into a new kidney care company.
- CEO cites ongoing macroeconomic and supply chain headwinds weighing on performance.
- Guidance for 2023 provided in full press release; no specific numbers in excerpt.

## SEC filing metadata
- accession: 0001628280-23-002862
- form_type: 8-K
- ticker: BAX
- cik: 0000010456
- company_name: BAXTER INTERNATIONAL INC
- filed_at: 2023-02-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10456/000162828023002862/0001628280-23-002862-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10456/000162828023002862/bax-20230209.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-002862
- JSON: https://secwatch.observer/filing/0001628280-23-002862.json
- Plain text: https://secwatch.observer/filing/0001628280-23-002862.txt

## Key facts
- Earnings Releases
  BAXTER INTERNATIONAL INC reported financial results for the fourth quarter and full year ended Dec. 31, 2022.
  - Period: the fourth quarter and full year ended Dec. 31, 2022
  - Result: reported results
  source text: On February 9, 2023 , Baxter International Inc. (the Company) issued an earnings press release for the period ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/10456/000162828023002862/0001628280-23-002862-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.